| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.206 | 0.033 | 0.206 | Phosphodiesterase inhibitor | |||
| 0.259 | 0.093 | 0.259 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.166 | 0.014 | 0.166 | Transcription factor STAT6 inhibitor | |||
| 0.173 | 0.04 | 0.173 | MAP kinase 3 inhibitor | |||
| 0.257 | 0.139 | 0.257 | Calcium channel activator | |||
| 0.208 | 0.102 | 0.208 | Tumour necrosis factor alpha release inhibitor | |||
| 0.172 | 0.068 | 0.172 | Heat shock protein 90 alpha antagonist | |||
| 0.119 | 0.015 | 0.119 | Protein kinase B beta inhibitor | 0.079 0.044 CID_154699849 | ||
| 0.131 | 0.035 | 0.131 | Pim-1 kinase inhibitor | |||
| 0.183 | 0.091 | 0.183 | Pyruvate kinase inhibitor | |||
| 0.299 | 0.214 | 0.299 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.086 | 0.032 | 0.086 | Phosphodiesterase 4B inhibitor | |||
| 0.074 | 0.024 | 0.074 | Phosphodiesterase 4C inhibitor | |||
| 0.087 | 0.037 | 0.087 | Protein kinase B alpha inhibitor | |||
| 0.164 | 0.113 | 0.164 | Anticonvulsant | |||
| 0.145 | 0.106 | 0.145 | Tumour necrosis factor antagonist | |||
| 0.11 | 0.074 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.147 | 0.113 | 0.147 | Death-associated protein kinase 2 inhibitor | |||
| 0.056 | 0.024 | 0.056 | Phosphodiesterase 10A inhibitor | |||
| 0.056 | 0.024 | 0.056 | Phosphodiesterase X inhibitor | |||
| 0.078 | 0.046 | 0.078 | Histone deacetylase stimulant | |||
| 0.078 | 0.046 | 0.078 | Histone deacetylase SIRT1 stimulant | |||
| 0.094 | 0.064 | 0.094 | Phosphodiesterase 7B inhibitor | |||
| 0.128 | 0.1 | 0.128 | Heat shock protein 90 antagonist | |||
| 0.054 | 0.028 | 0.054 | Bromodomain-containing protein 3 inhibitor | |||
| 0.073 | 0.047 | 0.073 | Phosphodiesterase VIII inhibitor | |||
| 0.062 | 0.043 | 0.062 | Phosphodiesterase 1C inhibitor | |||
| 0.047 | 0.029 | 0.047 | Phosphodiesterase 6C inhibitor | |||
| 0.034 | 0.015 | 0.034 | Histone deacetylase class II inhibitor | |||
| 0.029 | 0.016 | 0.029 | Histone deacetylase class IIb inhibitor | |||
| 0.029 | 0.016 | 0.029 | Histone deacetylase 6 inhibitor | |||
| 0.115 | 0.105 | 0.115 | Peroxidase inhibitor | |||
| 0.053 | 0.043 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.184 | 0.176 | 0.184 | MAP kinase kinase 3 inhibitor | |||
| 0.096 | 0.088 | 0.096 | MAP kinase 13 inhibitor | |||
| 0.058 | 0.052 | 0.058 | 5 Hydroxytryptamine 3 agonist | |||
| 0.084 | 0.079 | 0.084 | DNA directed RNA polymerase inhibitor | |||
| 0.074 | 0.068 | 0.074 | Phosphodiesterase IV inhibitor | |||
| 0.189 | 0.186 | 0.189 | Caspase 3 stimulant | |||
| 0.028 | 0.027 | 0.028 | Histone deacetylase 5 inhibitor | |||
| 0.188 | 0.217 | 0.308 | Histamine release inhibitor | 0.308 0.119 CID_154699849 | CID_154699849 | |
| 0.131 | 0.255 | 0.211 | RNA-directed DNA polymerase inhibitor | 0.211 0.084 CID_154699849 | CID_154699849 | |
| 0.011 | 0.371 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 CID_154699849 | CID_154699849 | |
| 0.024 | 0.436 | 0.117 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 CID_154699849 | CID_154699849 | |
| 0.013 | 0.718 | 0.232 | Angiogenesis stimulant | 0.232 0.078 CID_154699849 | CID_154699849 | |
| 0.005 | 0.745 | 0.131 | Diuretic | 0.131 0.094 CID_154699849 | CID_154699849 | |
| 0.01 | 0.758 | 0.216 | Dual specificity phosphatase inhibitor | 0.216 0.047 CID_154699849 | CID_154699849 | |
| 0.008 | 0.763 | 0.223 | Dual specificity phosphatase 3 inhibitor | 0.223 0.05 CID_154699849 | CID_154699849 | |
| 0.007 | 0.791 | 0.128 | Cholecystokinin B agonist | 0.128 0.005 CID_154699849 | CID_154699849 | |
| 0.002 | 0.818 | 0.074 | Cholecystokinin A agonist | 0.074 0.004 CID_154699849 | CID_154699849 | |
| 0.005 | 0.844 | 0.071 | CDC25A inhibitor | 0.071 0.055 CID_154699849 | CID_154699849 | |
| 0.002 | 0.843 | 0.075 | Cholecystokinin agonist | 0.075 0.005 CID_154699849 | CID_154699849 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |